Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-96,729
Closed -$6.05M 712
2025
Q4
$6.05M Sell
96,729
-20,597
-18% -$1.22M 0.03% 354
2025
Q3
$6.78M Sell
117,326
-7,995
-6% -$428K 0.04% 322
2025
Q2
$6.16M Buy
125,321
+46,746
+59% +$2.15M 0.04% 320
2025
Q1
$3.47M Buy
78,575
+58,586
+293% +$2.91M 0.02% 401
2024
Q4
$940K Buy
+19,989
New +$963K 0.01% 590
2023
Q2
Sell
-32,175
Closed -$983K 785
2023
Q1
$983K Sell
32,175
-22,402
-41% -$691K 0.01% 700
2022
Q4
$1.49M Buy
54,577
+1,498
+3% +$43.5K 0.01% 625
2022
Q3
$1.51M Buy
+53,079
New +$1.59M 0.01% 644
2022
Q2
Sell
-15,601
Closed -$585K 796
2022
Q1
$585K Sell
15,601
-23,719
-60% -$930K ﹤0.01% 733
2021
Q4
$1.67M Sell
39,320
-66,674
-63% -$2.64M 0.01% 580
2021
Q3
$3.87M Sell
105,994
-38,580
-27% -$1.42M 0.03% 445
2021
Q2
$5.34M Buy
144,574
+83,826
+138% +$2.93M 0.04% 392
2021
Q1
$1.63M Hold
60,748
0.01% 558
2020
Q4
$1.7M Buy
60,748
+14,551
+31% +$358K 0.01% 570
2020
Q3
$907K Sell
46,197
-5,607
-11% -$104K 0.01% 627
2020
Q2
$800K Buy
+51,804
New +$765K 0.01% 634
2019
Q4
Sell
-9,095
Closed -$323K 795
2019
Q3
$323K Buy
+9,095
New +$342K ﹤0.01% 712
2019
Q1
Sell
-17,083
Closed -$518K 808
2018
Q4
$518K Sell
17,083
-3,521
-17% -$109K 0.01% 681
2018
Q3
$626K Buy
20,604
+20,573
+66,365% +$598K 0.01% 685
2018
Q2
$1K Sell
31
-82,219
-100% -$2.39M ﹤0.01% 779
2018
Q1
$2.37M Sell
82,250
-56,512
-41% -$1.75M 0.04% 442
2017
Q4
$4.5M Buy
+138,762
New +$4.33M 0.08% 286
2016
Q4
Sell
-90,254
Closed -$2.52M 678
2016
Q3
$2.52M Sell
90,254
-43,894
-33% -$1.3M 0.06% 310
2016
Q2
$3.91M Buy
+134,148
New +$4M 0.1% 220

Other funds holding GIL

Candriam SCA's GIL Position: Q1 2026 in Review

Candriam SCA sold out of Gildan (GIL) in Q1 2026, closing a stake of 96,729 shares — an estimated $6.05M sold.

Candriam SCA first reported a position in GIL in Q2 2016 and held it in 24 quarters. The position peaked at $6.78M in Q3 2025. 485 funds tracked by Wall St. Rank hold GIL as of Q1 2026.

  • Candriam SCA reported no remaining Gildan position as of Q1 2026 after selling out during the quarter.
  • Candriam SCA sold 96,729 Gildan shares in Q1 2026, an estimated $6.05M.
  • Candriam SCA first reported a position in Gildan in Q2 2016 and held it in 24 quarters.
  • Candriam SCA's Gildan position peaked at $6.78M in Q3 2025.
  • 485 funds tracked by Wall St. Rank held Gildan as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.